Research indicates GLP-1RAs may decrease limb complications in type 2 diabetes with PAD, though more randomized studies are ...

Amputation in type 1 diabetes is becoming relatively less common in Sweden. The rate has fallen by just over 40 percent over an approximately 20-year period, a University of Gothenburg study shows.

Glucagon‐like peptide‐1 receptor agonists (GLP-1 RAs) were shown to be associated with lower risks of death, hospitalization, ...

Amputation in type 1 diabetes is becoming relatively less common in Sweden. The rate has fallen by just over 40 percent over an approximately 20-year period, a University of Gothenburg study shows.

According to new, independent research published in the Journal of the American Heart Association, GLP-1 receptor agonist ...

Diabetes-related amputations have reversed a decade-long trend and are now on the rise, according to the American Diabetes Association (ADA). ADA’s Amputation Prevention Alliance reports that 154,000 ...

When a person loses a hand to amputation, nerves that control sensation and movement are severed, causing dramatic changes in areas of the brain that controlled these functions. As a result, areas of ...

Rogelio Jacinto had five days until doctors planned to amputate his leg. It was an emotionally wrenching end to five months of unsuccessful visits to specialists to treat a diabetic foot ulcer. The 72 ...

A two-fold higher incidence of lower limb amputation, primarily of the toe, has been seen in a clinical trial with canagliflozin, Janssen, the European Medicines Agency (EMA) and UK’s Medicines and ...

CAMBRIDGE, Mass. — For hours on end last year, Massachusetts Institute of Technology engineers ran the brain-controlled robotic limb through its paces, testing its capabilities on a series of patients ...

For patients with peripheral artery disease (PAD) and type 2 diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) ...